Publications & Presentations

Vectra Da

Publications & Presentations

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study

Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.

A Multi-Biomarker Disease Activity (Vectra DA) Algorithm Score for Rheumatoid Arthritis Predicts Radiographic Progression in the BeSt Study.

Evaluation of Definitions of Rheumatoid Arthritis Remission by Assessing Radiographic Progression in the Leiden Early Arthritis Cohort.

Investigation of a Multi-Biomarker Disease Activity (Vectra DA) Signature and Algorithm Score in Rheumatoid Arthritis Patients with Low Disease Activity: The REMIRA Study.

A Novel Multi-Biomarker Disease Activity Score (Vectra™DA algorithm score) Reflects Clinical Disease Activity Score and Health Assessment Questionnaire for Rheumatoid Arthritis in the BeSt Study.

Multi-Biomarker Disease Activity Score (Vectra™DA algorithm score) Reflects Clinical Disease Activity and Tracks Response in a Japanese Rheumatoid Arthritis Population Treated with Anti-TNF Therapy

Development of a Multi-Biomarker Structural Damage Score in Rheumatoid Arthritis to Predict Radiographic Progression in the Leiden Early Arthritis Cohort

Development of a High-Throughput, Multiplex Assay for Profiling the Autoantibody Fine Specificity in Rheumatoid Arthritis

A Multi-Biomarker Algorithm for RA Disease Activity (Vectra™ DA) Predicts Radiographic Progression in the BeSt Study.

©2018 Crescendo Bioscience, Inc. All rights reserved. Vectra, Crescendo Bioscience, MyRA and the associated logos are trademarks or registered trademarks of Crescendo Bioscience, Inc. in the United States and other jurisdictions.